MELISSA BRAND: Open Payments
NPI 1669035325 · ELMIRA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$703 in 32 payments from 8 companies in 2025. Trend: 2023 $23 · 2024 $1,083 · 2025 $703
Food & beverage: $703
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $236 |
| Amgen Inc. | 9 | $183 |
| Novartis Pharmaceuticals Corporation | 6 | $138 |
| PFIZER INC. | 2 | $45 |
| Boston Scientific Corporation | 1 | $41 |
| Exact Sciences Corporation | 1 | $26 |
| Janssen Biotech, Inc. | 1 | $21 |
| Genentech USA, Inc. | 1 | $14 |
Products named: RINVOQ, COSENTYX, TAVNEOS, OTEZLA, SKYRIZI, XELJANZ, WaveWriter Alpha Prime 16, EVENITY.
Industry payments across NY — which companies pay providers there.
